The compound 1,8-cineole demonstrated the downregulation of inflammatory responses in dextran sulfate sodium (DSS)-induced colitis in mice and decreased proinflammatory chemokine production in TNF-stimulated HT-29 cells, proving to be a potent compound in treating human IBD [53]. This evidence concerns the gene TNF and colitis.